Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00775320 · ClinicalTrials.gov registry record
Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET
A clinical trial, sponsored by University of Oklahoma.
- Terminated
- Registry status
- 13
- Enrollment target
NCT00775320: Clinical Trial study, sponsored by University of Oklahoma.
NCT00775320 is a clinical trial that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00775320 was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The primary objective of this study is to detect and quantify tumor cells of high grade malignant gliomas and metastatic brain lesions both before and after initial surgical resection in a cohort of newly diagnosed patients.
Interventions
- PROCEDURE FLT-PET scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-08 |
Why NCT00775320 stopped before completion
NCT00775320 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FLT-PET scan is the first listed.
NCT00775320 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00775320 about?
NCT00775320 is a clinical study titled "Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET". The primary objective of this study is to detect and quantify tumor cells of high grade malignant gliomas and metastatic brain lesions both before and after initial surgical resection in a cohort of newly diagnosed patients.
What is the current status of trial NCT00775320?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2008-10. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00775320?
The interventions under investigation include: FLT-PET scan (PROCEDURE).
Who is sponsoring clinical trial NCT00775320?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia